tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market

NRX Pharmaceuticals (NRXP) Income Statement

Compare
425 Followers

NRX Pharmaceuticals Income Statement

Last quarter (Q3 2024), NRX Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NRX Pharmaceuticals's net income was $-1.62M. See NRX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.00K$ -4.00K$ -2.00K$ -907.41K$ 0.00
Operating Expenses
$ 27.58M$ 44.40M$ 94.43M$ 11.90M-
Depreciation and Amortization
$ 5.00K$ 4.00K$ 2.00K$ 2.00K-
EBITDA
$ -30.02M$ -39.75M$ -93.04M$ -51.72M$ -713.19K
Operating Income
$ -27.59M$ -44.40M$ -115.80M$ -51.39M-
Other Income/Expenses
$ -2.57M$ 4.58M$ 22.73M$ -39.88M$ 1.21M
Pretax Income
$ -30.16M$ -39.82M$ -93.06M$ -51.78M$ 492.63K
Net Income
$ -30.15M$ -35.23M$ -71.72M$ -12.35M$ 408.43K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.98$ -0.54$ -1.53$ -0.36$ 0.80
Diluted EPS
$ -3.98$ -0.54$ -1.53$ -0.36$ 0.80
Weighted Average Shares Outstanding
7.58M 65.77M 46.92M 34.27M 508.83K
Weighted Average Shares Outstanding (Diluted)
7.58M 65.77M 46.92M 34.27M 508.83K
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis